3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
19
Carcinoma, Non-Small-Cell Lung
9
Rhabdomyosarcoma
6
Triple Negative Breast Neoplasms
5
Hodgkin Disease
4
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Adenocarcinoma
2
Solitary Fibrous Tumor, Pleural
1
NSCLC
1
Metastatic HER2-positive Breast Cancer
1
Mesothelioma, Malignant
1
Lung Diseases, Interstitial
1
Locally Advanced Non-Small Cell Lung Cancer
1
HR+HER2- Breast Cancer
1
Fludzoparib" and Anti-angiogenic
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Large Cell
1
Advanced Breast Cancer
1
Interventions
Radiotherapy
4
osimertinib
3
aflutinib
3
Radiosurgery
3
Pemetrexed
3
Drug Therapy
3
Carboplatin
3
toripalimab
2
pembrolizumab
2
Docetaxel
2
tislelizumab
1
sugemalimab
1
lenvatinib
1
cemiplimab
1
brigatinib
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Surgical Procedures, Operative
1
S 1 (combination)
1
Platinum Compounds
1
Platinum
1
Pharmaceutical Preparations
1
Paclitaxel
1
Neoadjuvant Therapy
1
JDQ443
1
Immune Checkpoint Inhibitors
1
HM781-36B
1
Gemcitabine
1
Diphenhydramine
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NSCLC
×
Vinorelbine
×
1 year
×
Clear all
NCT06576635
2026-01-20
LUNG-05
University of Illinois at Chicago
Phase NA
Recruiting
29 enrolled